SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 168 filers reported holding SHOCKWAVE MED INC in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,099,580 | -23.9% | 85,854 | +9.0% | 0.01% | -14.3% |
| Q2 2023 | $22,475,258 | +19.7% | 78,747 | -9.0% | 0.01% | +16.7% |
| Q1 2023 | $18,769,858 | +100451.0% | 86,571 | -4.6% | 0.01% | 0.0% |
| Q4 2022 | $18,667 | -99.9% | 90,785 | +3.4% | 0.01% | -33.3% |
| Q3 2022 | $24,409,000 | +66.7% | 87,780 | +14.6% | 0.01% | +80.0% |
| Q2 2022 | $14,644,000 | -19.7% | 76,599 | -12.9% | 0.01% | -16.7% |
| Q1 2022 | $18,229,000 | +11.2% | 87,924 | -4.3% | 0.01% | +20.0% |
| Q4 2021 | $16,388,000 | -20.4% | 91,896 | -8.1% | 0.01% | -28.6% |
| Q3 2021 | $20,586,000 | +2.7% | 99,993 | -5.3% | 0.01% | +16.7% |
| Q2 2021 | $20,042,000 | +47.6% | 105,631 | +1.3% | 0.01% | +50.0% |
| Q1 2021 | $13,578,000 | +10.8% | 104,247 | -11.8% | 0.00% | 0.0% |
| Q4 2020 | $12,257,000 | +49.8% | 118,192 | +9.5% | 0.00% | +33.3% |
| Q3 2020 | $8,184,000 | +292.9% | 107,978 | +145.4% | 0.00% | +200.0% |
| Q2 2020 | $2,083,000 | – | 43,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |